Tom Foltynie, Dilan Athauda. Prog Brain Res 2020
Times Cited: 18
Times Cited: 18
Matthew J During, Lei Cao, David S Zuzga, Jeremy S Francis, Helen L Fitzsimons, Xiangyang Jiao, Ross J Bland, Matthias Klugmann, William A Banks, Daniel J Drucker, Colin N Haile. Nat Med 2003
Times Cited: 610
Times Cited: 610
List of shared articles
Times cited
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment.
Stefan Trapp, Daniel I Brierley. Br J Pharmacol 2022
Stefan Trapp, Daniel I Brierley. Br J Pharmacol 2022
Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases.
Shang-Der Chen, Yao-Chung Chuang, Tsu-Kung Lin, Jenq-Lin Yang. Eur J Pharmacol 2023
Shang-Der Chen, Yao-Chung Chuang, Tsu-Kung Lin, Jenq-Lin Yang. Eur J Pharmacol 2023
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, Nigel H Greig. Pharmacol Res 2022
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, Nigel H Greig. Pharmacol Res 2022